![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Innovision Res. | LSE:INN | London | Ordinary Share | GB0030308448 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 34.75 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number : 5370I Innovision Research&Technology PLC 20 November 2008 Innovision Research & Technology plc ("Innovision R&T") Board Appointment The Board of Innovision R&T is pleased to announce the appointment to the Board of Dr Stephen Morris as CTO with effect from 19 November 2008. Steve joined Innovision R&T in September 2008 and has a wide range of experience of systems and complex mixed-signal IC design gained from senior positions within UK and US based organisations. He is a visiting Professor at the University of Westminster, has authored nearly 30 scientific papers and contributed to several books on IC design and data converters. He is a Fellow of the IET. Malcolm Baggott, Non-executive Chairman, said "We welcome Steve to the Board. His proven knowledge and wide experience within IC design will undoubtedly help guide and deliver the technical strategy and IP roadmap for the company over the coming years." Dr Stephen John Morris, aged 59, has and/or has held the following directorships and/or partnerships in the last 5 years: Current directorships: Past directorships: Manor Farm Winterbourne Bassett Limited None As at the date of this announcement, Dr Stephen Morris holds 10,000 ordinary shares of 1p each in Innovision R&T. Dr Stephen Morris confirms that there are no additional disclosures required to be made pursuant to paragraph (g) of Schedule 2 to the AIM Rules. Enquiries: Innovision Research & Technology Plc Tel: 01285 888 200 David Wollen, Chief Executive Brian McKenzie, Finance Director KBC Peel Hunt Ltd (Nominated Adviser and Broker) Tel: 020 7418 8900 Oliver Scott / David Anderson This information is provided by RNS The company news service from the London Stock Exchange END BOAKGMMMRLMGRZM
1 Year Innovision Research&technology Chart |
1 Month Innovision Research&technology Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions